USA • New York Stock Exchange • NYSE:LH • US5049221055
The current stock price of LH is 276.14 USD. In the past month the price increased by 9.66%. In the past year, price increased by 12.98%.
ChartMill assigns a technical rating of 9 / 10 to LH. When comparing the yearly performance of all stocks, LH is one of the better performing stocks in the market, outperforming 71.69% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 15.82. The EPS increased by 9.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.21% | ||
| ROA | 4.68% | ||
| ROE | 9.83% | ||
| Debt/Equity | 0.59 |
29 analysts have analysed LH and the average price target is 305.75 USD. This implies a price increase of 10.72% is expected in the next year compared to the current price of 276.14.
For the next year, analysts expect an EPS growth of 15.38% and a revenue growth 7.75% for LH
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.83 | 96.896B | ||
| CI | THE CIGNA GROUP | 9.37 | 76.006B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 93.98 | 23.171B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.42 | 21.391B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.673B | ||
| DVA | DAVITA INC | 10.76 | 10.535B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 28.91 | 6.918B | ||
| CHE | CHEMED CORP | 17.57 | 6.42B | ||
| OPCH | OPTION CARE HEALTH INC | 17.83 | 5.424B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 70000
Phone: 13362291127
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
The current stock price of LH is 276.14 USD. The price decreased by -0.75% in the last trading session.
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.07%. The yearly dividend amount is currently 2.91.
LH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.
The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.67% of its float.